Release Date: 29/12/14 16:32 Summary: Upgrade of Resource & Scoping Study Price Sensitive: Yes Download Document 1.52MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%